LEM-mR203
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LEM-mR203, covering 2025-04-06 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203) [Phase 1]